Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience.
Peter SchullianEdward JohnstonGregor LaimerDaniel PutzerGernot EberleArno AmannMaria EffenbergerManuel MaglioneMartin C FreundAlexander LoizidesReto BalePublished in: European radiology (2020)
• In 1235 ablation sessions in 793 patients over 15 years, we found a mortality rate of 0.5% (6/1235) and an overall major complication rate of 7.4%, which fell from 11.5 (36/314) to 6.0% (55/921, p = 0.001) after January 2011, likely due to procedural adaptations. • History of bile duct surgery/intervention (p = 0.013, OR = 3.290), number of coaxial needles (p = 0.026, OR = 1.052), and location of tumors in segment IVa (p = 0.016, OR = 1.989) or VIII (p = 0.038, OR = 1.635) were found to be independent prognostic factors. • Simple logistic regression revealed that number of tumors, tumor size, location close to the diaphragm, tumor conglomerates, and segment VII were other significant predictors of major complications.
Keyphrases
- prognostic factors
- radiofrequency ablation
- end stage renal disease
- randomized controlled trial
- minimally invasive
- ejection fraction
- newly diagnosed
- chronic kidney disease
- cardiovascular events
- type diabetes
- single cell
- mechanical ventilation
- coronary artery disease
- catheter ablation
- acute respiratory distress syndrome